Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2022
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition period from ____ to ____
Commission file number 1-11314
LTC PROPERTIES, INC.
(Exact name of Registrant as specified in its charter)
Maryland
71-0720518
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
2829 Townsgate Road, Suite 350
Westlake Village, California 91361
(Address of principal executive offices, including zip code)
(805) 981-8655
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common stock, $.01 par value
LTC
New York Stock Exchange
Indicate by check mark whether registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ◻
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ◻
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ
Accelerated filer ◻
Non-accelerated filer ◻
Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨◻
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No þ
The number of shares of common stock outstanding on April 21, 2022 was 39,462,229.
March 31, 2022
INDEX
PART I -- Financial Information
Page
Item 1.
Financial Statements
Consolidated Balance Sheets
3
Consolidated Statements of Income
4
Consolidated Statements of Comprehensive Income
5
Consolidated Statements of Equity
6
Consolidated Statements of Cash Flows
7
Notes to Consolidated Financial Statements
8
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
24
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
45
Item 4.
Controls and Procedures
46
PART II -- Other Information
Legal Proceedings
47
Item 1A.
Risk Factors
Unregistered Sales of Equity Securities and Use of Proceeds
Item 6.
Exhibits
48
CONSOLIDATED BALANCE SHEETS
(amounts in thousands, except per share)
December 31, 2021
ASSETS
(unaudited)
(audited)
Investments:
Land
$
120,203
123,239
Buildings and improvements
1,240,713
1,285,318
Accumulated depreciation and amortization
(367,623)
(374,606)
Operating real estate property, net
993,293
1,033,951
Properties held-for-sale, net of accumulated depreciation: 2022—$16,396; 2021—$0
32,313
—
Real property investments, net
1,025,606
Mortgage loans receivable, net of credit loss reserve: 2022—$3,494; 2021—$3,473
346,543
344,442
Real estate investments, net
1,372,149
1,378,393
Notes receivable, net of credit loss reserve: 2022—$619; 2021—$286
61,508
28,337
Investments in unconsolidated joint ventures
19,340
Investments, net
1,452,997
1,426,070
Other assets:
Cash and cash equivalents
4,393
5,161
Debt issue costs related to revolving line of credit
2,883
3,057
Interest receivable
41,165
39,522
Straight-line rent receivable
23,912
24,146
Lease incentives
2,277
2,678
Prepaid expenses and other assets
8,470
4,191
Total assets
1,536,097
1,504,825
LIABILITIES
Revolving line of credit
157,900
110,900
Term loans, net of debt issue costs: 2022—$600; 2021—$637
99,400
99,363
Senior unsecured notes, net of debt issue costs: 2022—$498; 2021—$524
505,482
512,456
Accrued interest
3,090
3,745
Accrued expenses and other liabilities
27,626
33,234
Total liabilities
793,498
759,698
EQUITY
Stockholders’ equity:
Common stock: $0.01 par value; 60,000 shares authorized; shares issued and outstanding: 2022—39,460; 2021—39,374
395
394
Capital in excess of par value
857,558
856,895
Cumulative net income
1,459,048
1,444,636
Accumulated other comprehensive income (loss)
4,704
(172)
Cumulative distributions
(1,587,519)
(1,565,039)
Total LTC Properties, Inc. stockholders’ equity
734,186
736,714
Non-controlling interests
8,413
Total equity
742,599
745,127
Total liabilities and equity
See accompanying notes.
CONSOLIDATED STATEMENTS OF INCOME
(amounts in thousands, except per share, unaudited)
Three Months Ended
March 31,
2022
2021
Revenues:
Rental income
30,324
31,973
Interest income from mortgage loans
9,636
7,922
Interest and other income
827
385
Total revenues
40,787
40,280
Expenses:
Interest expense
7,143
6,972
Depreciation and amortization
9,438
9,877
Provision (recovery) for credit losses
354
(9)
Transaction costs
32
92
Property tax expense
3,982
3,981
General and administrative expenses
5,808
5,033
Total expenses
26,757
25,946
Other operating income:
Gain (loss) on sale of real estate, net
102
(773)
Operating income
14,132
13,561
Income from unconsolidated joint ventures
375
289
Net income
14,507
13,850
Income allocated to non-controlling interests
(95)
(88)
Net income attributable to LTC Properties, Inc.
14,412
13,762
Income allocated to participating securities
(137)
(120)
Net income available to common stockholders
14,275
13,642
Weighted average shares used to calculate earnings per common share:
Basic
39,199
39,100
Diluted
39,349
39,179
Dividends declared and paid per common share
0.57
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(amounts in thousands, unaudited)
Three Months Ended March 31,
Unrealized gain on cash flow hedges before reclassification
4,584
Losses reclassified from accumulated other comprehensive income to interest expense
292
Comprehensive income
19,383
CONSOLIDATED STATEMENTS OF EQUITY
(In thousands)
Capital in
Cumulative
Total
Non-
Common Stock
Excess of
Net
Accumulated
Stockholder's
Controlling
Shares
Amount
Par Value
Income
OCI
Distributions
Equity
Interests
Balance—December 31, 2020
39,242
392
852,780
1,388,775
(1,474,545)
767,402
8,404
775,806
Common Stock cash distributions ($0.57 per share)
(22,405)
Vesting of performance-based stock units, including the payment of distributions
109
1
(1)
(764)
Stock-based compensation expense
1,852
88
Non-controlling interest distributions
Cash paid for taxes in lieu of common shares
(84)
(3,470)
Other
95
(11)
(10)
Balance—March 31, 2021
39,362
851,150
1,402,537
(1,497,714)
756,367
764,771
(22,439)
-
1,958
18,239
91
18,330
(91)
(3)
(103)
15
(46)
Balance—June 30, 2021
39,374
852,959
1,420,776
(1,520,153)
753,976
762,380
(22,443)
1,975
11,022
11,114
(92)
Non-controlling interest contributions
9
(13)
Balance—September 30, 2021
854,921
1,431,798
(1,542,596)
744,517
752,930
12,838
12,930
Fair market valuation adjustment for interest rate swap
Balance—December 31, 2021
(22,480)
1,925
(37)
(1,255)
4,876
123
(7)
(6)
Balance—March 31, 2022
39,460
CONSOLIDATED STATEMENTS OF CASH FLOWS
OPERATING ACTIVITIES:
Adjustments to reconcile net income to net cash provided by operating activities:
(Gain) loss on sale of real estate, net
(102)
773
(375)
(289)
Income distributions from unconsolidated joint ventures
164
Straight-line rental adjustment (income)
234
(682)
Adjustment for collectability of rental income and lease incentives
173
758
Amortization of lease incentives
223
112
Other non-cash items, net
(957)
260
Change in operating assets and liabilities
Lease incentives funded
(8)
Increase in interest receivable
(1,643)
(1,745)
Decrease in accrued interest payable
(655)
(869)
Net change in other assets and liabilities
(4,546)
(2,793)
Net cash provided by operating activities
18,568
21,259
INVESTING ACTIVITIES:
Investment in real estate capital improvements
(1,068)
(1,044)
Proceeds from sale of real estate, net
1,765
Investment in real estate mortgage loans receivable
(1,026)
(158)
Principal payments received on mortgage loans receivable
125
(5,676)
Advances and originations under notes receivable
(34,791)
(1,656)
Principal payments received on notes receivable
1,287
2,553
Net cash used in investing activities
(35,473)
(4,091)
FINANCING ACTIVITIES:
Borrowings from revolving line of credit
47,000
17,000
Principal payments on senior unsecured notes
(7,000)
Distributions paid to stockholders
(23,169)
Distributions paid to non-controlling interests
Financing costs paid
(27)
Cash paid for taxes in lieu of shares upon vesting of restricted stock and performance-based stock units
(12)
Net cash provided by (used in) financing activities
16,137
(16,739)
(Decrease) increase in cash and cash equivalents
(768)
429
Cash and cash equivalents, beginning of period
7,772
Cash and cash equivalents, end of period
8,201
Supplemental disclosure of cash flow information:
Interest paid
7,534
7,582
Non-cash investing and financing transactions:
Preferred return reserve related to investments in unconsolidated joint ventures (See Footnote 3)
2,324
Application of interest reserve recorded as mortgage loan receivable
1,221
Increase in fair value of interest rate swap agreements (See Footnote 6)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1.
General
LTC Properties, Inc., a health care real estate investment trust (“REIT”), was incorporated on May 12, 1992 in the State of Maryland and commenced operations on August 25, 1992. We invest primarily in seniors housing and health care properties primarily through sale-leasebacks, mortgage financing, joint ventures and structured finance solutions including preferred equity and mezzanine lending. We conduct and manage our business as one operating segment, rather than multiple operating segments, for internal reporting and internal decision-making purposes. Our primary objectives are to create, sustain and enhance stockholder equity value and provide current income for distribution to stockholders through real estate investments in seniors housing and health care properties managed by experienced operators. Our primary seniors housing and health care property classifications include skilled nursing centers (“SNF”), assisted living communities (“ALF”), independent living communities (“ILF”), memory care communities (“MC”) and combinations thereof. We also invest in other (“OTH”) types of properties, such as land parcels, projects under development (“UDP”) and behavioral health care hospitals. To meet these objectives, we attempt to invest in properties that provide opportunity for additional value and current returns to our stockholders and diversify our investment portfolio by geographic location, operator, property classification and form of investment.
We have prepared consolidated financial statements included herein without audit and in the opinion of management have included all adjustments necessary for a fair presentation of the consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to rules and regulations governing the presentation of interim financial statements. The accompanying consolidated financial statements include the accounts of our company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the three ended March 31, 2022 and 2021 are not necessarily indicative of the results for a full year.
No provision has been made for federal or state income taxes. Our company qualifies as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended. As such, we generally are not taxed on income that is distributed to our stockholders.
2.
Real Estate Investments
Assisted living communities, independent living communities, memory care communities and combinations thereof are included in the assisted living property classification (collectively “ALF”).
Any reference to the number of properties or facilities, number of units, number of beds, number of operators and yield on investments in real estate are unaudited and outside the scope of our independent registered public accounting firm’s review of our consolidated financial statements in accordance with the standards of the Public Company Accounting Oversight Board.
Owned Properties. Our owned properties are leased pursuant to non-cancelable operating leases. Each lease is a triple net lease which requires the lessee to pay all taxes, insurance, maintenance and repairs, capital and non-capital expenditures and other costs necessary in the operations of the facilities. Many of the leases contain renewal options. The majority of our leases contain provisions for specified annual increases over the rents of the prior year.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS CONTINUED
The following table summarizes our investments in owned properties at March 31, 2022 (dollar amounts in thousands):
Average
Percentage
Number
Number of
Investment
Gross
of
SNF
ALF
per
Type of Property
Properties (1)
Beds
Units
Bed/Unit
Assisted Living
844,995
59.9
%
5,798
145.74
Skilled Nursing
553,073
39.3
50
6,154
212
86.88
Other (2)
11,557
0.8
118
1,409,625
100.0
153
6,272
6,010
Future minimum base rents receivable under the remaining non-cancelable terms of operating leases excluding the effects of straight-line rent receivable, amortization of lease incentives and renewal options are as follows (in thousands):
Cash
Rent (1)
85,484
2023
101,561
2024
96,676
2025
88,161
2026
71,761
Thereafter
276,323
We monitor the collectability of our receivable balances, including deferred rent receivable balances, on an ongoing basis. We write-off uncollectible operator receivable balances, including straight- line rent receivable and lease incentives balances, as a reduction to rental income in the period such balances are no longer probable of being collected. Therefore, recognition of rental income is limited to the lesser of the amount of cash collected or rental income reflected on a “straight-line” basis for those customer receivable balances deemed uncollectible. We wrote-off straight-line rent receivable and lease incentives balances of $173,000 and $758,000 for the three months ended March 31, 2022 and 2021, respectively.
We continue to take into account the current financial condition of our operators, including consideration of the impact of COVID-19, in our estimation of uncollectible accounts and deferred rents receivable at March 31, 2022. We are closely monitoring the collectability of such rents and will adjust future estimations as appropriate as further information becomes known.
The following table summarizes components of our rental income for the three months ended March 31, 2022 and 2021 (in thousands):
Rental Income
Base cash rental income
26,915
28,623
Variable cash rental income
4,039
(2)
3,538
Straight-line rent
(234)
682
(173)
(4)
(758)
(5)
(223)
(112)
Some of our lease agreements provide purchase options allowing the lessees to purchase the properties they currently lease from us. The following table summarizes information about purchase options included in our lease agreements (dollar amounts in thousands):
Type
Carrying
Option
State
Property
Properties
Investments
Value
Window
California
ALF/MC
2
38,895
34,425
2024-2029
31,814
16,765
2022-2023
Florida
MC
15,201
12,842
2029
Kentucky and Ohio
30,421
26,393
Nebraska
7,633
3,128
TBD
South Carolina
11,680
9,486
135,644
103,039
On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 as a pandemic, and on March 13, 2020, the United States declared a national emergency with regard to
10
COVID-19. At March 31, 2022, in conjunction with the continued levels of uncertainty related to the adverse effects of COVID-19, we assessed the probability of collecting substantially all of our lease payments through maturity and concluded that we did not have sufficient information available to evaluate the impact of COVID-19 on the collectability of our lease payments. The extent to which COVID-19 could impact our operators and the collectability of our future lease payments will depend on the future developments including the financial impact significance, government support and subsidies and the duration of the pandemic.
In recognition of the pandemic’s ongoing impact affecting our operators, we have agreed to rent abatements totaling $720,000 and rent deferrals for certain operators totaling $1,295,000 during the three months ended March 31, 2022. The $2,015,000 in rent abatements and deferrals during the three months ended March 31, 2022, represented approximately 5.4% of our contractual rent for the three months ended March 31, 2022.
Acquisitions and Developments: We had no acquisitions during the three months ended March 31, 2022 and 2021. Subsequent to March 31, 2022, we acquired four skilled nursing centers for $51,534,000. The properties, which are located in Texas, have a combined total of 339 beds primarily in private rooms and will be operated by an existing operator under a 10-year lease with two 5-year renewal options. Additionally, the lease provides either an earn-out payment or purchase option but not both. If neither option is elected within the timeframe defined in the lease, both elections are terminated. The earn-out payment is available, contingent on achieving certain thresholds per the lease, beginning at the end of the second lease year through the end of the fifth lease year. The purchase option is available beginning at the end of the fifth lease year through the end of the seventh lease year. The initial cash yield is 8% for the first year, increasing to 8.25% for the second year, then increases annually by 2.0% to 4.0% based on the change in the Medicare Market Basket Rate. In conjunction with the transaction, we provided the lessee a 10-year working capital loan for up to $2,000,000, of which $1,867,000 has been funded, at 8% for first year, increasing to 8.25% for the second year, then increasing annually with the lease rate.
During the three months ended March 31, 2022 and 2021, we invested the following in development and improvement projects (in thousands):
Developments
Improvements
Assisted Living Communities
694
1,044
Skilled Nursing Centers
177
197
1,068
11
Properties Sold. The following table summarizes property sales during the three months ended March 31, 2022 and 2021 (dollar amounts in thousands):
Sales
Year (1)
Beds/Units
Price
Gain (loss) (2)
n/a
2,000
2,625
(861)
Total 2021
(
Mortgage Loans. The following table summarizes our investments in mortgage loans secured by first mortgages at March 31, 2022 (dollar amounts in thousands):
Interest Rate
Maturity
Loans (1)
Properties (2)
7.5%
MO
1,780
OTH
0.5
LA
27,277
7.8
189
144.32
7.8%
FL
12,126
3.5
68
178.32
7.3% (4)
NC/SC
49,834
14.2
13
523
95.28
10.4% (5)
2043
MI
185,356
53.0
1,875
98.86
9.5% (5)
2045
39,039
11.2
501
77.92
9.6% (5)
19,750
5.6
205
96.34
10.0% (5)
14,875
4.2
146
101.88
350,037
37
2,916
591
99.81
12
The following table summarizes our mortgage loan activity for the three months ended March 31, 2022 and 2021 (in thousands):
Originations and funding under mortgage loans receivable
1,026
158
Application of interest reserve
1,223
Scheduled principal payments received
(125)
Mortgage loan premium amortization
Provision for credit losses
(21)
Net increase in mortgage loans receivable
2,101
31
We apply ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and the “expected loss” model to estimate our loan losses on our mortgage loans and notes receivable. In determining the expected losses on these receivables, we utilize the probability of default and discounted cash flow methods. Further, we stress-test the results to reflect the impact of unknown adverse future events including recessions.
As of March 31, 2022, the accrued interest receivable of $41,165,000 was not included in the measurement of expected credit losses on the mortgage loan receivable and notes receivable (see Note 4). We elected not to measure an allowance for expected credit losses on the related accrued interest receivable using the expected credit loss standard. Rather, we have elected to write-off accrued interest receivable by reversing interest income and/or recognizing credit loss expense as incurred. We review the collectability of the accrued interest receivable quarterly as part of our review of the mortgage loan or notes receivables including the performance of the underlying collateral. For the three months ended March 31, 2022 and 2021, the Company did not write-off any accrued interest receivable.
3.
Investment in Unconsolidated Joint Ventures
We have preferred equity investments in two joint ventures (“JVs”). We determined that each of these JVs meets the accounting criteria to be considered a variable interest entity (“VIE”). We are not the primary beneficiary of the JVs as we do not have the power to direct the activities that most significantly affect the JVs’ economic performance. However, we do have significant influence over the JVs. Therefore, we have accounted for the JVs using the equity method of accounting. The following table provides information regarding these preferred equity investments (dollar amounts in thousands):
Contractual
Preferred
Return
Portion
Beds/ Units
Washington
Preferred Equity
6,340
UDP
13,000
The following table summarizes our capital contributions, income recognized, and cash interest received related to our investments in unconsolidated joint ventures for the three months ended March 31, 2022 and 2021 (in thousands):
Capital
Cash Interest
Year
Contribution
Recognized
Earned
UDP (1)
263
75
8,000
89
14
4.
Notes Receivable
Notes receivable consists of mezzanine loans and other loan arrangements. The following table is a summary of our notes receivable components as of March 31, 2022 and December 31, 2021 (in thousands):
Mezzanine loans (1)
36,815
11,815
Other loans
25,312
16,808
Notes receivable credit loss reserve
(619)
(286)
The following table summarizes our notes receivable activity for the three months ended March 31, 2022 and 2021 (in thousands):
Three months March 31,
Advances under notes receivable
34,791
1,656
Principal payments received under notes receivable
(1,287)
(2,553)
(333)
Net increase (decrease) in notes receivable
33,171
(888)
5.
Lease Incentives
Our non-contingent lease incentive balances at March 31, 2022 and December 31, 2021 were $2,277,000 and $2,678,000. The following table summarizes our lease incentives activity for the three months ended March 31, 2022 and 2021 (in thousands):
Adjustment
Funding
Amortization
Write-off
Non-contingent lease incentives
Non-contingent lease incentives represent payments made to our lessees for various reasons including entering into a new lease or lease amendments and extensions. Contingent lease incentives represent potential contingent earn-out payments that may be made to our lessees in the future, as part of our lease agreements. From time to time, we may commit to provide contingent payments to our lessees, upon our properties achieving certain rent coverage ratios. Once the contingent payment becomes probable and estimable, the contingent payment is recorded as a lease incentive. Lease incentives are amortized as a yield adjustment to rental income over the remaining life of the lease.
6.
Debt Obligations
Unsecured Credit Facility. We have an unsecured credit agreement (the “Credit Agreement”) that provides for an aggregate commitment of the lenders of up to $500,000,000 comprising of a $400,000,000 revolving credit facility (the “Revolving Line of Credit”) and two $50,000,000 term loans (the “Term Loans”). The Credit Agreement permits us to request increases to the Revolving Line of Credit and Term Loans commitments up to a total of $1,000,000,000, extends the maturity of the Revolving Line of Credit to November 19, 2025 and provides for a one-year extension option at our discretion, subject to customary conditions. The Term Loans mature on November 19, 2025 and November 19, 2026.
Based on our leverage at March 31, 2022, the facility provides for interest annually at LIBOR plus 115 basis points and a facility fee of 20 basis points. At March 31, 2022, we were in compliance with all covenants.
Interest Rate Swap Agreements. In connection with entering into the Term Loans as discussed above, we entered into two receive variable/pay fixed interest rate swap agreements (“Interest Rate Swaps”) with maturities of November 19, 2025 and November 19, 2026, respectively, that will effectively lock-in the forecasted interest payments on the Term Loans’ borrowings over the four and five year terms of the loans. The Interest Rate Swaps are considered cash flow hedges and are recorded on our Consolidated Balance Sheets at fair value in prepaid expenses and other assets, with cumulative changes in the fair value of these instruments recognized in Accumulated other comprehensive income (loss) on our Consolidated Balance Sheets. During the three months ended March 31, 2022 and 2021, we recorded a $4,876,000 and $0 increase in fair value of Interest Rate Swaps.
As of March 31, 2022 and December 31, 2021, the terms of our Interest Rate Swaps are as follows (dollar amounts in thousands):
Notional
Fair Value at
Date Entered
Maturity Date
Swap Rate
Rate Index
November 2021
November 19, 2025
2.56
1-month LIBOR
50,000
2,245
November 19, 2026
2.69
2,459
100,000
Senior Unsecured Notes. We have senior unsecured notes held by institutional investors with interest rates ranging from 3.85% to 5.03%. The senior unsecured notes mature between 2024 and 2032.
The following table sets forth information regarding debt obligations by component as of March 31, 2022 and December 31, 2021 (dollar amounts in thousands):
At March 31, 2022
At December 31, 2021
Applicable
Available
Interest
Outstanding
for
Rate (1)
Balance
Borrowing
Revolving line of credit (2)
1.60%
242,100
289,100
Term loans, net of debt issue costs
2.63%
Senior unsecured notes, net of debt issue costs
4.35%
3.55%
762,782
722,719
16
Our borrowings and repayments are as follows (in thousands):
Borrowings
Repayments
Senior unsecured notes
7.
Non-controlling Interests. We have entered into partnerships to develop and/or own real estate. Given that our limited members do not have the substantive kick-out rights, liquidation rights, or participation rights, we have concluded that the partnerships are VIEs. As we exercise power over and receive benefits from the VIEs, we are considered the primary beneficiary. Accordingly, we consolidate the VIEs and record the non-controlling interests on the consolidated financial statements.
As of March 31, 2022, we have the following consolidated VIEs (in thousands):
Consolidated
Non-Controlling
Purpose
Assets
2019
Owned real estate
VA
16,895
919
2018
ILF
14,470
2,857
Owned real estate and development
18,447
1,091
2017
ILF/ALF/MC
WI
22,007
2,305
SC
1,241
83,499
Common Stock. We have separate equity distribution agreements (collectively, “Equity Distribution Agreements”) to offer and sell, from time to time, up to $200,000,000 in aggregate offering price of shares of our common stock. As of March 31, 2022, no shares had been issued under the Equity Distribution Agreements. Accordingly, at March 31, 2022, we had $200,000,000 available under the Equity Distribution Agreements.
During the three months ended March 31, 2022 and 2021, we acquired 36,880 shares and 84,616 shares, respectively, of common stock held by employees who tendered owned shares to satisfy tax withholding obligations.
Available Shelf Registration. We have an automatic shelf registration statement on file with the SEC, and currently have the ability to file additional automatic shelf registration statements, to provide us with capacity to publicly offer an indeterminate amount of common stock, preferred stock, warrants, debt,
17
depositary shares, or units. We may from time to time raise capital under our automatic shelf registration statement in amounts, at prices, and on terms to be announced when and if the securities are offered. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of the offering. Our shelf registration statement expires on February 17, 2025.
Distributions. We declared and paid the following cash dividends (in thousands):
Three Months March 31,
Declared
Paid
Common Stock (1)
22,480
23,169
In April 2022, we declared a monthly cash dividend of $0.19 per share on our common stock for the months of April, May and June 2022, payable on April 29, May 31, and June 30, 2022, respectively, to stockholders of record on April 21, May 23, and June 22, 2022, respectively.
Stock-Based Compensation. During the second quarter of 2021, we adopted and our shareholders approved the 2021 Equity Participation Plan (“the 2021 Plan”) which replaces the 2015 Equity Participation Plan (“the 2015 Plan”). Under the 2021 Plan, 1,900,000 shares of common stock have been authorized and reserved for awards, less one share for every one share that was subject to an award granted under the 2015 Plan after December 31, 2020 and prior to adoption. In addition, any shares that are not issued under outstanding awards under the 2015 Plan because the shares were forfeited or cancelled after December 31, 2020 will be added to and again be available for awards under the 2021 Plan. Under the 2021 Plan, the shares were authorized and reserved for awards to officers, employees, non-employee directors and consultants. The terms of the awards granted under the 2021 Plan and the 2015 Plan are set by our compensation committee at its discretion.
At March 31, 2022, we had 10,000 stock options outstanding and exercisable. During the three months ended March 31, 2022, 5,000 stock options expired and were cancelled. During the three months ended March 31, 2022 and 2021, no stock options were granted or exercised.
The following table summarizes our restricted stock activity for the three months ended March 31, 2022 and 2021:
Outstanding, January 1
197,422
180,440
Granted
122,865
95,293
Vested
(83,341)
(78,482)
Outstanding, March 31
236,946
197,251
18
During the three months ended March 31, 2022 and 2021, we granted 86,332 and 71,892, respectively, of performance-based stock units. Additionally, no performance-based stock units vested during the three months ended March 31, 2022 and 108,720 performance-based stock units vested during the three months ended March 31, 2021.
During the three months ended March 31, 2022 and 2021, we granted restricted stock and performance-based stock units under the 2021 Plan and 2015 Plan as follows:
No. of
Price per
Shares/Units
Share
Vesting Period
33.94
ratably over 3 years
86,332
TSR targets (1)
209,197
42.27
71,892
167,185
Compensation expense recognized related to the vesting of restricted common stock and performance-based stock units for the three months ended March 31, 2022 and 2021 were $1,925,000 and $1,852,000, respectively. At March 31, 2022, the remaining compensation expense to be recognized related to the future service period of unvested outstanding restricted common stock and performance-based stock units are as follows (in thousands):
Remaining
Compensation
Vesting Date
Expense
Nine months ended December 31, 2022
5,762
5,405
2,853
309
14,329
19
8.
Commitments and Contingencies
At March 31, 2022, we had commitments as follows (in thousands):
Commitment
Funded
Real estate properties (Footnote 2. Real Estate Investments)
13,235
948
2,587
10,648
Accrued incentives and earn-out liabilities (Footnote 5. Lease Incentives) (3)
9,000
Mortgage loans (Footnote 2. Real Estate Investments)
31,575
376
4,172
27,403
Notes receivable (Footnote 4. Notes Receivable)
25,250
9,791
18,892
6,358
79,060
11,115
25,651
53,409
Also, some of our lease agreements provide purchase options allowing the lessee to purchase the properties they currently lease from us. See Footnote 2. Real Estate Investments for a table summarizing information about our purchase options.
We are a party from time to time to various general and professional liability claims and lawsuits asserted against the lessees or borrowers of our properties, which in our opinion are not singularly or in the aggregate material to our results of operations or financial condition. These types of claims and lawsuits may include matters involving general or professional liability, which we believe under applicable legal principles are not our responsibility as a non-possessory landlord or mortgage holder. We believe that these matters are the responsibility of our lessees and borrowers pursuant to general legal principles and pursuant to insurance and indemnification provisions in the applicable leases or mortgages. We intend to continue to vigorously defend such claims.
9.
Major Operators
We have one operator that represents 10% or more of our combined rental revenue and interest income from mortgage loans. The following table sets forth information regarding our major operator as of March 31, 2022:
Percentage of
Operator
Revenue (1)
Assets (2)
Prestige Healthcare (3)
2,845
93
20.4
17.2
20
Our financial position and ability to make distributions may be adversely affected if Prestige Healthcare or any of our lessees and borrowers face financial difficulties, including any bankruptcies, inability to emerge from bankruptcy, insolvency or general downturn in business of any such operator, continuing impact upon services or occupancy levels due to COVID-19, or in the event any such operator does not renew and/or extend its relationship with us.
10.
Earnings per Share
The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share amounts):
Less income allocated to non-controlling interests
Less income allocated to participating securities:
Non-forfeitable dividends on participating securities
Effect of dilutive securities:
Participating securities (1)
Net income for diluted net income per share
Shares for basic net income per share
Stock options
Performance-based stock units
150
78
Total effect of dilutive securities
79
Shares for diluted net income per share
Basic net income per share
0.36
0.35
Diluted net income per share
11.
Fair Value Measurements
In accordance with the accounting guidance regarding the fair value option for financial assets and financial liabilities, entities are permitted to choose to measure certain financial assets and liabilities at fair value, with the change in unrealized gains and losses reported in earnings. We did not elect the fair value option for any of our financial assets and financial liabilities.
As of March 31, 2022, we had two interest rate swaps that were designated as cash flow hedges of interest rate risk with a total notional amount of $100,000,000. See Footnote 6. Debt Obligations within our consolidated financial statements for further detail on our interest rate swaps. We record cash flow hedges either as an asset or a liability measured at fair value. We estimate the fair value of our interest rate swaps using the assistance of a third-party using inputs that are observable in the market which include forward yield curves and other relevant information. Although we have determined that the
21
majority of the inputs used to value our derivative instruments fall within level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize level 3 inputs to evaluate the likelihood of default by us and our counterparties.
The carrying amount of cash and cash equivalents, prepaid expenses and other assets, accrued interest, accrued expenses and other liabilities approximates fair value because of the short-term maturity of these instruments. We do not invest our cash in auction rate securities. The carrying value and estimated fair value of our financial instruments as of March 31, 2022 and December 31, 2021 were as follows (in thousands):
Fair
Mortgage loans receivable, net of credit loss reserve
406,669
405,162
Notes receivable, net of credit loss reserve
66,576
28,653
503,887
540,045
12.
Subsequent Events
Subsequent to March 31, 2022 the following events occurred:
Real Estate Investments: We acquired four skilled nursing centers for $51,534,000. The properties, which are located in Texas, have a combined total of 339 beds primarily in private rooms and will be operated by an existing operator under a 10-year lease with two 5-year renewal options. Additionally, the lease provides either an earn-out payment or purchase option but not both. If neither option is elected within the timeframe defined in the lease, both elections are terminated. The earn-out payment is available, contingent on achieving certain thresholds per the lease, beginning at the end of the second lease year through the end of the fifth lease year. The purchase option is available beginning at the end of the fifth lease year through the end of the seventh lease year. The initial cash yield is 8% for the first year, increasing to 8.25% for the second year, then increases annually by 2.0% to 4.0% based on the change in the Medicare Market Basket Rate. In conjunction with the transaction, we provided the lessee a working
22
capital loan for up to $2,000,000, of which $1,867,000 has been funded, at the same yields and maturity as the lease.
Real Estate Dispositions: We sold a 74-unit assisted living community in Virginia for $16,895,000. The community had a gross book value of $16,895,000 and a book value of $15,549,000 at March 31, 2022. We anticipate recognizing a gain on sale of approximately $1,300,000 in the second quarter of 2022. In connection with the sale, the current operator paid us a lease termination fee of approximately $1,200,000.
Debt: We borrowed $52,000,000 and repaid $18,000,000 under our revolving line of credit. Accordingly, we have $191,900,000 outstanding and $208,100,000 available for borrowing under our revolving line of credit.
Equity: We declared a monthly cash dividend of $0.19 per share on our common stock for the months of April, May and June 2022, payable on April 29, May 31, and June 30, 2022, respectively to stockholders of record on April 21, May 23, and June 22, 2022, respectively.
23
Item 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Cautionary Statement Regarding Forward-Looking Statements
This quarterly report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, adopted pursuant to the Private Securities Litigation Reform Act of 1995. Statements that are not purely historical may be forward-looking. You can identify some of the forward-looking statements by their use of forward-looking words, such as “believes,” “expects,” “may,” “will,” “could,” “would,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates” or “anticipates,” or the negative of those words or similar words. Forward-looking statements involve inherent risks and uncertainties regarding events, conditions and financial trends that may affect our future plans of operation, business strategy, results of operations and financial position. A number of important factors could cause actual results to differ materially from those included within or contemplated by such forward-looking statements, including, but not limited to, our dependence on our operators for revenue and cash flow; the duration and extent of the effects of the COVID-19 pandemic; government regulation of the health care industry; federal and state health care cost containment measures including reductions in reimbursement from third-party payors such as Medicare and Medicaid; required regulatory approvals for operation of health care facilities; a failure to comply with federal, state, or local regulations for the operation of health care facilities; the adequacy of insurance coverage maintained by our operators; our reliance on a few major operators; our ability to renew leases or enter into favorable terms of renewals or new leases; the impact of inflation, operator financial or legal difficulties; the sufficiency of collateral securing mortgage loans; an impairment of our real estate investments; the relative illiquidity of our real estate investments; our ability to develop and complete construction projects; our ability to invest cash proceeds for health care properties; a failure to qualify as a REIT; our ability to grow if access to capital is limited; and a failure to maintain or increase our dividend. For a discussion of these and other factors that could cause actual results to differ from those contemplated in the forward-looking statements, please see the discussion under “Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in our publicly available filings with the Securities and Exchange Commission. We do not undertake any responsibility to update or revise any of these factors or to announce publicly any revisions to forward-looking statements, whether as a result of new information, future events or otherwise.
Executive Overview
Business and Investment Strategy
We are a real estate investment trust (“REIT”) that invests in seniors housing and health care properties through sale-leaseback transactions, mortgage financing, joint ventures, construction financing and structured finance solutions including mezzanine lending. Our primary objectives are to create, sustain and enhance stockholder equity value and provide current income for distribution to stockholders through real estate investments in seniors housing and health care properties managed by experienced operators.
The following graph summarizes our gross investments as of March 31, 2022:
Our primary seniors housing and health care property classifications include skilled nursing centers (“SNF”), assisted living communities (“ALF”), independent living communities (“ILF”), memory care communities (“MC”) and combinations thereof. We conduct and manage our business as one operating segment, rather than multiple operating segments, for internal reporting and internal decision-making purposes. For purposes of this quarterly report and other presentations, we generally include ALF, ILF, MC, and combinations thereof in the ALF classification. As of March 31, 2022, seniors housing and long-term health care properties comprised approximately 98.6% of our investment portfolio. We have been operating since August 1992.
Substantially all of our revenues and sources of cash flows from operations are derived from operating lease rentals, interest earned on outstanding loans receivable and income from investments in unconsolidated joint ventures. Income from our investments in owned properties and mortgage loans represent our primary source of liquidity to fund distributions and are dependent upon the performance of the operators on their lease and loan obligations and the rates earned thereon. To the extent that the operators experience operating difficulties and are unable to generate sufficient cash to make payments to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. To mitigate this risk, we monitor our investments through a variety of methods determined by property type and operator. Our monitoring process includes periodic review of financial statements for each facility, periodic review of operator credit, scheduled property inspections and review of covenant compliance.
25
In addition to our monitoring and research efforts, we also structure our investments to help mitigate payment risk. Some operating leases and loans are credit enhanced by guaranties and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other loans, operating leases or agreements between us and the operator and its affiliates.
Depending upon the availability and cost of external capital, we anticipate making additional investments in health care related properties. New investments are generally funded from cash on hand, proceeds from periodic asset sales, temporary borrowings under our unsecured revolving line of credit and internally generated cash flows. Our investments generate internal cash from rent and interest receipts and principal payments on mortgage loans receivable. Permanent financing for future investments, which replaces funds drawn under our unsecured revolving line of credit, is expected to be provided through a combination of public and private offerings of debt and equity securities. We could also look to secured and unsecured debt financing. The timing, source and amount of cash flows provided by financing activities and used in investing activities are sensitive to the capital markets’ environment, especially to changes in interest rates. Changes in the capital markets’ environment may impact the availability of cost-effective capital.
We believe our business model has enabled and will continue to enable us to maintain the integrity of our property investments, including in response to financial difficulties that may be experienced by operators. Traditionally, we have taken a conservative approach to managing our business, choosing to maintain liquidity and exercise patience until favorable investment opportunities arise.
COVID-19
On March 11, 2020, the World Health Organization declared the outbreak of coronavirus (“COVID-19”) as a pandemic, and on March 13, 2020, the United States declared a national emergency with regard to COVID-19. The COVID-19 pandemic has had repercussions across regional and global economies and financial markets. The outbreak of COVID-19 in many countries, including the United States, has significantly and adversely impacted public health and economic activity, and has contributed to significant volatility, dislocations and liquidity disruptions in financial markets.
The operations and occupancy levels at our properties have been adversely affected by COVID-19 and could be further adversely affected by COVID-19 or another pandemic especially if there are infections on a large scale at our properties. The impact of COVID-19 has included, and another pandemic could include, early resident move-outs, our operators delaying accepting new residents due to quarantines, potential occupants postponing moves to our operators’ facilities, and/or hospitals cancelling or significantly reducing elective surgeries thereby there were fewer people in need of skilled nursing care. Additionally, as our operators have responded to the pandemic, operating costs have begun to rise. A decrease in occupancy, ability to collect rents from residents and/or increase in operating costs could have a material adverse effect on the ability of our operators to meet their financial and other contractual obligations to us, including the payment of rent. In recognition of the ongoing pandemic impact affecting our operators, we have agreed to rent abatements totaling $5.2 million and rent deferrals for certain operators totaling $8.7 million between April 2020 and March 2022, of which $1.7 million subsequently has been repaid. The $12.2 million in rent abatements and deferrals, net of repayments, represented approximately 3.4% of our April 2020 through March 2022 contractual rent and interest. The remaining balance of deferred rent is due to us over the next 36 months or upon receipt of government funds from the U.S. Coronavirus Aid, Relief, and Economic Security (the “CARES Act”).
26
During the three months ended March 31, 2021, we proactively provided additional financial support to the majority of our operators by reducing 2021 rent and interest escalations by 50%. The rent and interest escalation reduction were given in the form of a rent and interest credit in recognition of operators’ increased costs due to COVID-19. During three months ended March 31, 2021, we recognized a Generally Accepted Accounting Principles (“GAAP”) revenue decrease of $0.3 million and a cash revenue decrease of $1.2 million related to the 50% escalation reduction.
27
Real Estate Portfolio Overview
The following tables summarize our real estate investment portfolio by owned properties and mortgage loans and by property type, as of March 31, 2022 (dollar amounts in thousands):
Rental
of Total
Owned Properties
Revenue
Revenues
45.9
14,216
38.2
30.1
11,884
32.0
0.6
242
0.7
Total Owned Properties
76.6
26,342
(4)
70.9
Interest Income
from Mortgage
Mortgage Loans
Loans
61,960
3.4
1,179
3.2
286,297
15.5
8,423
22.7
Other (3)
0.1
34
Total Mortgage Loans
19.0
26.0
and other
Assisted Living (5)
961
43,347
2.4
629
1.7
Skilled Nursing (6)
18,780
1.0
160
0.4
Total Notes Receivable
62,127
789
2.1
Income from
Unconsolidated
Unconsolidated Joint Ventures
Joint Ventures
Assisted Living (7)
0.3
Under Development (8)
Total Unconsolidated Joint Ventures
Total Portfolio
198
9,188
7,657
1,841,129
37,142
Summary of Properties by Type
124
7,445
956,642
52.0
73
9,070
858,150
46.6
Under Development
Other (2) (3)
13,337
28
As of March 31, 2022, we had $1.5 billion in net carrying value of investments, consisting of $1.0 billion or 70.6% invested in owned and leased properties and $0.3 billion or 23.9% invested in mortgage loans secured by first mortgages. Our investment in mortgage loans mature between 2022 and 2045 and contain interest rates between 7.3% and 10.4%.
For the three months ended March 31, 2022, rental income represented 74.4% of total gross revenues, interest income from mortgage loans represented 23.6% of total gross revenues and interest and other income represented 2.0% of total gross revenues. In most instances, our lease structure contains fixed annual rental escalations and/or annual rental escalations that are contingent upon changes in the Consumer Price Index. Certain leases have annual rental escalations that are contingent upon changes in the gross operating revenues of the property. This revenue is not recognized until the appropriate contingencies have been resolved.
For the three months ended March 31, 2022, we recorded $0.2 million in straight-line rental adjustment and amortization of lease incentive cost of $0.2 million. Also, during the first quarter of 2022, we wrote-off a $0.2 million lease incentive balance related to a property closure and subsequent lease termination. During the three months ended March 31, 2022, we received $31.0 million of cash rental income, which includes $4.0 million of operator reimbursements for our real estate taxes. At March 31, 2022, the straight-line rent receivable balance on the consolidated balance sheet was $23.9 million.
Update on Certain Operators and Former Operators
Anthem Memory Care
Anthem Memory Care (“Anthem”) operates 11 memory care communities under a master lease and was placed in default in 2017 resulting from Anthem’s partial payment of its minimum rent. However, we did not enforce our rights and remedies pertaining to the event of default, under the stipulation that Anthem achieves sufficient performance and pays agreed upon rent. Anthem increased their rent payment every year between 2017 and 2021. Anthem paid us annual cash rent of $10.8 million in 2021 and $9.9 million in 2020. Recently, Anthem informed us that they may be unable to pay full agreed upon 2022 second quarter rent of $2.7 million. However, we anticipate receiving total cash rent from Anthem in 2022 of approximately $10.8 million. We receive regular financial performance updates from Anthem and continue to monitor their performance obligations under the master lease agreement. Anthem has paid their greed upon rent through April 2022.
Brookdale Senior Living Communities, Inc
Brookdale Senior Living Communities, Inc’s (“Brookdale”) master lease was amended in the first quarter of 2021 to extend the term by one year through December 31, 2022. The renewal options under the amended master lease remained the same during the first quarter of 2022 and provided three renewal options consisting of a three-year renewal option, a five-year renewal option and a 10-year renewal option. The notice period for the first renewal option was January 1, 2022 to April 30, 2022. Subsequent to March 31, 2022, Brookdale’s master lease was again amended to extend the maturity to December 31, 2023. The renewal options under the new amended master lease remained unchanged except the term of the first renewal option was reduced from three years to two. Also, the notice period for the first renewal option was changed to November 1, 2022 through February 28, 2023. During 2020, we extended to Brookdale a $4.0 million capital commitment which was fully funded during 2021, and a $2.0 million capital commitment which is available between January 1, 2022 through December 31, 2022. Under the new amendment, the $2.0 million capital commitment was increased to $4.0 million and the maturity was extended to February 28, 2023. The yield on these capital commitments is 7% with a reduced rate for
29
qualified ESG projects. During the three months ended March 31, 2022, we funded $0.2 million under the $4.0 million capital commitment. Accordingly, we have a remaining commitment of $3.8 million under this commitment. Brookdale is current on rent payments through April 2022.
Senior Lifestyle Corporation
During 2020, an affiliate of Senior Lifestyle (“Senior Lifestyle”) failed to pay its contractual obligations under its master lease. As a result, we applied their letter of credit and deposits to past due rent and to their outstanding notes receivable. Senior Lifestyle has not paid rent or its other obligations under the master lease since 2021. During 2021, we transition 18 assisted living communities previously leased to Senior Lifestyle to six operators. These communities are located in Illinois, Ohio, Wisconsin, Colorado, Pennsylvania and Nebraska. Also, during 2021, we sold three Wisconsin communities and a closed community in Nebraska previously leased to Senior Lifestyle for a combined total of $35.9 million. We received total proceeds of $34.8 million and recorded a net gain on sale of $5.4 million. We expect to transition the remaining New Jersey community to an existing operator during the second quarter of 2022. During the three months ended March 31, 2022, the assisted living community located in Colorado, which transitioned from Senior Lifestyle to a new operator during the first quarter of 2021, was closed and the lease was terminated. We have engaged a broker and intend to sell this assisted living community.
Other Operators
During 2020, we consolidated our two master leases with an operator into one combined master lease and agreed to abate $0.7 million of rent and allow the operator to defer rent as needed through March 31, 2021. The combined master lease was amended during 2021 and 2022 to extend the rent deferral period through April 30, 2022. The operator deferred rent of $1.3 million during the first quarter of 2022 and $0.4 million in April 2022. The deferred balance due from this operator is $6.6 million as of April 2022. We have not recorded this as revenue, nor have we abated the rent. We expect to address this deferred rent as we work with the operator toward a resolution for the portfolio.
Senior Care Centers, LLC – Former Operator
Senior Care Centers, LLC and affiliates and subsidiaries (“Senior Care”) filed for Chapter 11 bankruptcy in December 2018. During 2019, while in bankruptcy, Senior Care assumed LTC’s master lease and, in March 2020, Senior Care emerged from bankruptcy. Concurrent with their emergence from bankruptcy, in accordance with the order confirming Senior Care’s plan of reorganization, Abri Health Services, LLC (“Abri Health”) was formed as the parent company of reorganized Senior Care and became co-tenant and co-obligor with reorganized Senior Care under our master lease. In March 2021, Senior Care and Abri Health (collectively, “Lessee”) failed to pay rent and additional obligations owed under the master lease. Accordingly, we sent a notice of default and applied proceeds from letters of credit to certain obligations owed under the master lease. Furthermore, we sent the Lessee a notice of termination of the master lease to be effective April 17, 2021. On April 16, 2021, the Lessee filed for Chapter 11 bankruptcy. In August 2021, the United States Bankruptcy Court approved a settlement agreement between Lessee and LTC. The settlement provides for, among other things, a one-time payment of $3.3 million from LTC to the affiliates of Lessee in exchange for cooperation and assistance in facilitating an orderly transition of the 11 skilled nursing centers from the Lessee and its affiliates to affiliates of HMG Healthcare, LLC which occurred on October 1, 2021. As of October 1, 2021, Senior Care and Abri Health no longer operator any properties in our portfolio.
2022 Activities Overview
30
The following tables summarize our transactions during the three months ended March 31, 2022 (dollar amounts in thousands):
Acquisitions and Investment in Development and Improvement projects
We had no acquisitions during the three months ended March 31, 2022. Subsequent to March 31, 2022, we acquired four skilled nursing centers for $51.5 million. The properties, which are located in Texas, have a combined total of 339 beds primarily in private rooms and will be operated by an existing operator under a 10-year lease with two 5-year renewal options. Additionally, the lease provides either an earn-out payment or purchase option but not both. If neither option is elected within the timeframe defined in the lease, both elections are terminated. The earn-out payment is available, contingent on achieving certain thresholds per the lease, beginning at the end of the second lease year through the end of the fifth lease year. The purchase option is available beginning at the end of the fifth lease year through the end of the seventh lease year. The initial cash yield is 8% for the first year, increasing to 8.25% for the second year, then increases annually by 2.0% to 4.0% based on the change in the Medicare Market Basket Rate. In conjunction with the transaction, we provided the lessee a working capital loan for up to $2.0 million of which $1.9 million has been funded, at the same yields and maturity as the lease.
During the three months ended March 31, 2022, we invested the following in development and improvement projects (in thousands):
Properties Sold
(3) (4)
Investment in Mortgage Loans
Received
Washington (1)
(1)
Washington (2)
(2)
Net increase in notes receivable
Health Care Regulatory Climate
The Centers for Medicare & Medicaid Services (“CMS”) annually updates Medicare skilled nursing facility (“SNF”) prospective payment system rates and other policies. On July 30, 2019, CMS issued its final fiscal year 2020 Medicare skilled nursing facility update. Under the final rule, CMS projected aggregate payments to SNFs would increase by $851 million, or 2.4%, for fiscal year 2020 compared with fiscal year 2019. The final rule also addressed implementation of the new Patient-Driven Payment Model case mix classification system that became effective on October 1, 2019, changes to the group therapy definition in the skilled nursing facility setting, and various SNF Value-Based Purchasing and quality reporting program policies. On April 10, 2020, CMS issued a proposed rule to update SNF rates and policies for fiscal year 2021, which started October 1, 2020, and issued the final rule on July 31, 2020. CMS estimated that payments to SNFs would increase by $750 million, or 2.2%, for fiscal year 2021 compared to fiscal year 2020. CMS also adopted revised geographic delineations to identify a provider’s status as an urban or rural facility and to calculate the wage index, applying a 5% cap on any decreases in a provider’s wage index from fiscal year 2020 to fiscal year 2021. Finally, CMS also finalized updates to the SNF value-based purchasing program to reflect previously finalized policies, updated the 30-day phase one review and correction deadline for the baseline period quality measure quarterly report, and announced performance periods and performance standards for the fiscal year 2023 program year. On April 8, 2021, CMS issued a proposed rule to update SNF rates and policies for fiscal year 2022, which started October 1, 2021, and issued the final rule on July 29, 2021. CMS estimated that the aggregate impact of the payment policies in the final rule would result in an increase of approximately $410 million in Medicare Part A payments to SNFs in fiscal year 2022. The final rule also includes several policies that update the SNF Quality Reporting Program and the SNF Value-Based Program for fiscal year 2022. On April 11, 2022, CMS issued a proposed rule to update SNF rates and policies for fiscal year 2023. CMS estimates that the aggregate impact of the payment policies in the proposed rule would result in a decrease of approximately $320 million in Medicare Part A payments to SNFs in fiscal year 2023 compared to fiscal year 2022.
Since the announcement of the COVID-19 pandemic and beginning as of March 13, 2020, CMS has issued numerous temporary regulatory waivers and new rules to assist health care providers, including SNFs, respond to the COVID-19 pandemic. These include waiving the SNF 3-day qualifying inpatient hospital stay requirement, flexibility in calculating a new Medicare benefit period, waiving timing for completing functional assessments, waiving requirements for health care professional licensure, survey and certification, provider enrollment, and reimbursement for services performed by telehealth, among many others. CMS also announced a temporary expansion of its Accelerated and Advance Payment Program to allow SNFs and certain other Medicare providers to request accelerated or advance payments in an amount up to 100% of the Medicare Part A payments they received from October–December 2019; this expansion was suspended April 26, 2020 in light of other CARES Act funding relief. The Continuing Appropriations Acts, 2021 and Other Extensions Act, enacted on October 1, 2020, amended the repayment terms for all providers and suppliers that requested and received accelerated and advance payments during the COVID-19 public health emergency. Specifically, Congress gave providers and suppliers that received Medicare accelerated and advance payment(s) one year from when the first loan payment was made to begin making repayments. In addition, CMS has also enhanced requirements for nursing facilities to report COVID-19 infections to local, state and federal authorities. On April 12, 2022, HHS Secretary Becerra announced that he had renewed, effective April 16, 2022, the declared public health emergency for an additional 90-day period.
On March 26, 2020, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), sweeping legislation intended to bolster the nation’s response to the COVID-19 pandemic. In addition to offering economic relief to individuals and impacted businesses, the law expands coverage of COVID-19 testing and preventative services, addresses health care workforce
33
needs, eases restrictions on telehealth services during the crisis, and increases Medicare regulatory flexibility, among many other provisions. Notably, the CARES Act temporarily suspended the 2% across-the-board “sequestration” reduction during the period May 1, 2020 through December 31, 2020, and extended the current Medicare sequester requirement through fiscal year 2030. In addition, the law provides $100 billion in grants to eligible health care providers for health care related expenses or lost revenues that are attributable to COVID-19. On April 10, 2020, CMS announced the distribution of $30 billion in funds to Medicare providers based upon their 2019 Medicare fee for service revenues. Eligible providers were required to agree to certain terms and conditions in receiving these grants. In addition, the Department of Health and Human Services (“HHS”) authorized $20 billion of additional funding for providers that have already received funds from the initial distribution of $30 billion. Unlike the first round of funds, which came automatically, providers were required to apply for these additional funds and submit the required supporting documentation, using the online portal provided by HHS. Providers were required to attest to and agree to specific terms and conditions for the use of such funds. HHS expressed a goal of allocating the whole $50 billion proportionally across all providers based on those providers’ proportional share of 2018 net Medicare fee-for-service revenue, so that some providers will not be eligible for additional funds. On May 22, 2020, HHS announced that it had begun distributing $4.9 billion in additional relief funds to SNFs to offset revenue losses and assist nursing homes with additional costs related to responding to the COVID-19 public health emergency and the shipments of personal protective equipment provided to nursing homes by the Federal Emergency Management Agency. On June 9, 2020, HHS announced that it expected to distribute approximately $15 billion to eligible providers that participate in state Medicaid and Children’s Health Insurance Program (“CHIP”) programs and have not received a payment from the Provider Relief Fund General Allocation. On July 22, 2020, President Trump announced that HHS would devote $5 billion in Provider Relief Funds to Medicare-certified long-term care facilities and state veterans’ homes to build nursing home skills and enhance nursing homes’ response to COVID-19, including enhanced infection control. Nursing homes were required to participate in the Nursing Home COVID-19 training to qualify for this funding. On August 27, 2020, HHS announced that it had distributed almost $2.5 billion to nursing homes to support increased testing, staffing, and personal protective equipment needs. On September 3, 2020, HHS announced a $2 billion performance-based incentive payment distribution to nursing homes and SNFs. Finally, on October 1, 2020, HHS announced $20 billion in additional funding for several types of providers, including those who previously received, rejected, or accepted a general distribution provider relief fund payment. The application deadline for these Phase 3 funds was November 6, 2020.
On December 27, 2020, President Trump signed the Consolidated Appropriations Act, 2021 (H.R. 133). The $1.4 trillion omnibus appropriations legislation funds the government through September 30, 2021 and was attached to a $900 billion COVID-19 relief package. Of the $900 billion in COVID-19 relief, $73 billion was allocated to HHS. Notably, the bill adds an additional $3 billion to the Provider Relief Fund, includes language specific to reporting requirements, and allows providers to use any reasonable method to calculate lost revenue, including the difference between such provider’s budgeted and actual revenue budget if such budget had been established and approved prior to March 27, 2020, to demonstrate entitlement for these funds. This change reverts to HHS’ previous guidance from June 2020 on how to calculate lost revenues. The Consolidated Appropriations Act, 2021, also extended the CARES Act’s sequestration suspension to March 31, 2021. On January 15, 2021, HHS announced that it would be amending the reporting timeline for Provider Relief Funds and indicated that it was working to update the Provider Relief Fund requirements to be consistent with the passage of the Consolidated Appropriations Act, 2021.
On April 14, 2021, President Biden signed an Act to Prevent Across-the-Board Direct Spending Cuts, and for Other Purposes (H.R. 1868), which extended the sequestration suspension period to December 31, 2021. On June 11, 2021, HHS issued revised reporting requirements for recipients of Provider Relief Fund payments. The announcement included expanding the amount of time providers
would have to report information, aimed to reduce burdens on smaller providers, and extended key deadlines for expending Provider Relief Fund payments for recipients who received payments after June 30, 2020. The revised reporting requirements are applicable to providers who received one or more payments exceeding, in the aggregate, $10,000 during a single Payment Received Period from the PRF General Distributions, Targeted Distributions, and/or Skilled Nursing Facility and Nursing Home Infection Control Distributions. On July 1, 2021, HHS, through the Health Resources and Services Administration (“HRSA”), notified recipients of Provider Relief Fund payments by e-mail that the Provider Relief Fund Reporting Portal was open for recipients who were required to report on the use of funds in Reporting Period 1, as described by HHS’s June 11, 2021 update to the reporting requirements. On September 10, 2021, HHS announced a final 60-day grace period of the September 30, 2021 reporting deadline for Provider Relief Funds exceeding $10,000 in aggregate payments received from April 10, 2020 to June 30, 2020. Although the September 30, 2021 reporting deadline remained in place, HHS explained that recoupment or other enforcement actions would not be initiated during the 60-day grace period, which began on October 1, 2021 and ended on November 30, 2021. Reporting Period 2, for providers who received one or more payments exceeding $10,000, in the aggregate, from July 1, 2020 to December 31, 2020, was from January 1, 2022 to March 31, 2022. The Provider Relief Fund reporting portal will open for Reporting Period 3 on July 1, 2022, for providers who received one or more Provider Relief Fund payments exceeding $10,000, in the aggregate, from January 1, 2021 to June 30, 2021.
On September 10, 2021, the Biden Administration announced that HHS would be making available $25.5 billion in new funding for health care providers affected by the COVID-19 pandemic, including $8.5 billion in American Rescue Plan (“ARP”) resources for providers who serve rural Medicaid, CHIP, or Medicare patients, and an additional $17 billion for Phase 4 Provider Relief Funds for a broad range of providers who can document revenue loss and expenses associated with the pandemic, including assisted living facilities that were state-licensed/certified on or before December 31, 2020. Approximately 25% of the Phase 4 allocation will be put towards bonus payments based on the amount and type of services provided to Medicaid, CHIP, and Medicare beneficiaries from January 1, 2019 through September 30, 2020. The deadline for submitting applications for Phase 4 funds was October 26, 2021.
On December 10, 2021, President Biden signed the Protecting Medicare and American Farmers from Sequester Cuts Act, which suspended the Medicare 2% sequestration reduction through March 31, 2022, and then reduced the sequestration cuts to 1% from April through June 2022.
On December 14, 2021, HHS announced the distribution of approximately $9 billion in Provider Relief Fund Phase 4 payments to health care providers who have experienced revenue losses and expenses related to the COVID-19 pandemic. Further, on January 25, 2022, HHS announced that it would be making more than $2 billion in Provider Relief Fund Phase 4 General Distribution payments to more than 7,600 providers across the country that same week. On March 2022, HHS announced more than $413 million in Provider Relief Fund Phase 4 payments to more than 3,600 providers across the country.
On July 18, 2019, CMS published a final rule that eliminated the prohibition on pre-dispute binding arbitration agreements between long-term care facilities and their residents. The rule also strengthened the transparency of arbitration agreements and makes other changes to arbitration requirements for long-term care facilities. There can be no assurance that these rules or future regulations modifying Medicare skilled nursing facility payment rates or other requirements for Medicare and/or Medicaid participation will not have an adverse effect on the financial condition of our borrowers and lessees which could, in turn, adversely impact the timing or level of their payments to us.
Congress periodically considers legislation revising Medicare and Medicaid policies, including legislation that could have the impact of reducing Medicare reimbursement for SNFs and other Medicare
35
providers, limiting state Medicaid funding allotments, encouraging home and community-based long-term care services as an alternative to institutional settings, or otherwise reforming payment policy for post-acute care services. Congress continues to consider further legislative action in response to the COVID-19 pandemic. There can be no assurances that enacted or future legislation will not have an adverse impact on the financial condition of our lessees and borrowers, which subsequently could materially adversely impact our company.
Additional reforms affecting the payment for and availability of health care services have been proposed at the federal and state level and adopted by certain states. Increasingly, state Medicaid programs are providing coverage through managed care programs under contracts with private health plans, which is intended to decrease state Medicaid costs. State Medicaid budgets may experience shortfalls due to increased costs in addressing the COVID-19 pandemic. Congress and state legislatures can be expected to continue to review and assess alternative health care delivery systems and payment methodologies. Changes in the law, new interpretations of existing laws, or changes in payment methodologies may have a dramatic effect on the definition of permissible or impermissible activities, the relative costs associated with doing business and the amount of reimbursement by the government and other third-party payors.
Key Performance Indicators, Trends and Uncertainties
We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to concentration risk and credit strength. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results in making operating decisions and for budget planning purposes.
Concentration Risk. We evaluate by gross investment our concentration risk in terms of asset mix, real estate investment mix, operator mix and geographic mix. Concentration risk is valuable to understand what portion of our real estate investments could be at risk if certain sectors were to experience downturns. Asset mix measures the portion of our investments that are real property or mortgage loans. The National Association of Real Estate Investment Trusts (“NAREIT”), an organization representing U.S. REITs and publicly traded real estate companies, classifies a company with 50% or more of assets directly or indirectly in the equity ownership of real estate as an equity REIT. Investment mix measures the portion of our investments that relate to our various property classifications. Operator mix measures the portion of our investments that relate to our top five operators. Geographic mix measures the portion of our real estate investment that relate to our top five states.
36
The following table reflects our recent historical trends of concentration risk (gross investment, in thousands):
3/31/22
12/31/21
9/30/21
6/30/21
3/31/21
Asset mix:
Real property
1,408,557
1,407,098
1,412,329
1,449,062
Loans receivable
347,915
261,437
259,641
259,874
Notes receivable
18,864
13,869
13,714
Unconsolidated joint ventures
Real estate investment mix:
Assisted living communities
929,113
868,081
860,573
897,154
Skilled nursing centers
849,182
812,518
820,246
820,476
Under development
Other (1)
13,140
11,360
Operator mix:
Prestige Healthcare (1)
272,326
272,453
272,789
272,773
273,007
HMG Healthcare
180,662
171,920
23,705
139,176
Brookdale Senior Living
103,136
102,921
102,261
101,240
101,012
Carespring Health Care Management
102,697
102,520
Remaining operators
1,043,132
1,015,445
1,066,288
1,065,765
1,102,570
Geographic mix:
Michigan
281,407
281,512
282,022
281,762
281,995
Texas
274,803
274,626
274,204
273,588
273,468
Wisconsin
114,729
114,538
114,288
114,250
149,403
106,129
105,997
105,892
105,352
Colorado
104,514
104,445
104,347
104,307
Remaining states
959,547
923,116
825,783
825,340
827,465
Credit Strength. We measure our credit strength both in terms of leverage ratios and coverage ratios. Our leverage ratios include debt to gross asset value and debt to market capitalization. The leverage ratios indicate how much of our Consolidated Balance Sheets capitalization is related to long-term obligations. Our coverage ratios include interest coverage ratio and fixed charge coverage ratio. The coverage ratios indicate our ability to service interest and fixed charges (interest). The coverage ratios are based on earnings before interest, taxes, depreciation and amortization for real estate (“EBITDAre”) as defined by NAREIT. EBITDAre is calculated as net income available to common stockholders (computed in accordance with GAAP) excluding (i) interest expense, (ii) income tax expense, (iii) real estate depreciation and amortization, (iv) impairment write-downs of depreciable real estate, (v) gains or losses on the sale of depreciable real estate, and (vi) adjustments for unconsolidated partnerships and joint ventures. Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. The following table reflects the recent historical trends for our credit strength measures:
Balance Sheet Metrics
Quarter Ended
Debt to gross asset value
39.6
38.4
36.3
34.8
Debt to market capitalization ratio
33.4
35.0
(3)
34.7
29.0
(5)
28.7
Interest coverage ratio (7)
4.4
x
4.3
(6)
4.7
Fixed charge coverage ratio (7)
(Less)/Add: (Gain) loss on sale
(70)
(2,702)
(5,463)
Add: Interest expense
6,933
6,610
6,860
Add: Depreciation and amortization
9,449
9,462
9,508
EBITDAre
30,986
29,242
24,484
29,235
31,472
Add: Non-recurring one-time items
423
869
3,895
133
1,050
Adjusted EBITDAre
31,409
30,111
28,379
29,368
32,522
Interest incurred
Interest coverage ratio
Total fixed charges
Fixed charge coverage ratio
38
We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved, and actual results may differ materially from our expectations. This may be a result of various factors, including, but not limited to
Additionally, as described in the Executive Overview above, COVID-19 is adversely affecting and is expected to continue to adversely affect our business, results of operations, cash flows and financial condition. Depending on the future developments regarding COVID-19, the duration, spread and severity of the outbreak, historical trends reflected in our balance sheet metrics may not be achieved in the future.
Management regularly monitors the economic and other factors listed above. We develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends.
39
Operating Results (unaudited, in thousands)
Difference
(1,649)
1,714
442
507
(171)
439
(363)
60
(775)
(811)
(7)
(8)
875
571
86
657
650
(17)
633
40
Funds From Operations Available to Common Stockholders
Funds from Operations (“FFO”) attributable to common stockholders, basic FFO attributable to common stockholders per share and diluted FFO attributable to common stockholders per share are supplemental measures of a REIT’s financial performance that are not defined by GAAP. Real estate values historically rise and fall with market conditions, but cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. We believe that by excluding the effect of historical cost depreciation, which may be of limited relevance in evaluating current performance, FFO facilitates comparisons of operating performance between periods.
We use FFO as a supplemental performance measurement of our cash flow generated by operations. FFO does not represent cash generated from operating activities in accordance with GAAP, and is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income available to common stockholders.
We calculate and report FFO in accordance with the definition and interpretive guidelines issued by NAREIT. FFO, as defined by NAREIT, means net income available to common stockholders (computed in accordance with GAAP) excluding gains or losses on the sale of real estate and impairment write-downs of depreciable real estate plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. Our calculation of FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or that have a different interpretation of the current NAREIT definition from us; therefore, caution should be exercised when comparing our FFO to that of other REITs.
The following table reconciles GAAP net income available to common stockholders to NAREIT FFO available to common stockholders (unaudited, amounts in thousands, except per share amounts):
Three months ended
GAAP net income available to common stockholders
(Less)/Add: (Gain) loss on sale of real estate, net
NAREIT FFO attributable to common stockholders
23,611
24,292
NAREIT FFO attributable to common stockholders per share:
0.60
0.62
Weighted average shares used to calculate NAREIT FFO per share:
41
Liquidity and Capital Resources
Sources and Uses of Cash
As of March 31, 2022, we had a total of $4.4 million of cash and cash equivalents, $242.1 million available under our unsecured revolving line of credit and the potential ability to access the capital markets through the issuance of $200.0 million of common stock under our Equity Distribution Agreements. Furthermore, we have the ability to access the capital markets through the issuance of debt and/or equity securities under an automatic shelf registration statement.
We believe that our current cash balance, cash flow from operations available for distribution or reinvestment, our borrowing capacity and our potential ability to access the capital markets are sufficient to provide for payment of our current operating costs, meet debt obligations and pay common dividends at least sufficient to maintain our REIT status and repay borrowings at, or prior to, their maturity. The timing, source and amount of cash flows used in financing and investing activities are sensitive to the capital markets environment, especially to changes in interest rates. In addition, as described in “Item 1A. Risk Factors”, COVID-19 has adversely affected and is expected to continue to adversely affect our operators’ business, results of operations, cash flows and financial condition which could, in turn, adversely affect our financial position.
The operating results of the facilities will be impacted by various factors over which the operators/owners may have no control. Those factors include, without limitation, the health of the economy, changes in supply of or demand for competing seniors housing and health care facilities, ability to control rising operating costs, the potential for significant reforms in the health care industry, and the impact of COVID-19. In addition, our future growth in net income and cash flow may be adversely impacted by various proposals for changes in the governmental regulations and financing of the health care industry, and the impact of COVID-19. We cannot presently predict what impact these proposals may have, if any. We believe that an adequate provision has been made for the possibility of loans proving uncollectible but we will continually evaluate the financial status of the operations of the seniors housing and health care properties. In addition, we will monitor our borrowers and the underlying collateral for mortgage loans and will make future revisions to the provision, if considered necessary.
Depending on the duration, spread and severity of the COVID-19 outbreak, our borrowing capacity, compliance with financial covenants, ability to access the capital markets, and the payment of dividends may be negatively impacted. We continuously evaluate the availability of cost-effective capital and believe we have sufficient liquidity for corporate expenses and additional capital investments in 2022.
Our investments, principally our investments in owned properties and mortgage loans, are subject to the possibility of loss of their carrying values as a result of changes in market prices, interest rates and inflationary expectations. The effects on interest rates may affect our costs of financing our operations and the fair market value of our financial assets. Generally, our leases have agreed upon annual increases and our loans have predetermined increases in interest rates. Inasmuch as we may initially fund some of our investments with variable interest rate debt, we would be at risk of net interest margin deterioration if medium and long-term rates were to increase.
Our primary sources of cash include rent and interest receipts, borrowings under our unsecured credit facility, public and private issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures and construction advances), loan advances and general and
42
administrative expenses. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows as summarized below (in thousands):
Change
Cash provided by (used in):
Operating activities
(2,691)
Investing activities
(31,382)
Financing activities
32,876
(Decrease) increase in cash, cash equivalents and restricted cash
(1,197)
Cash, cash equivalents and restricted cash, beginning of period
(2,611)
Cash, cash equivalents and restricted cash, end of period
(3,808)
Unsecured Credit Facility. We have an unsecured credit agreement (the “Credit Agreement”) that provides for an aggregate commitment of the lenders of up to $500.0 million comprising of a $400.0 million revolving credit facility (the “Revolving Line of Credit”) and two $50.0 million term loans (the “Term Loans”). The Credit Agreement permits us to request increases to the Revolving Line of Credit and Term Loans commitments up to a total of $1.0 billion, extends the maturity of the Revolving Line of Credit to November 19, 2025 and provides for a one-year extension option at our discretion, subject to customary conditions. The Term Loans mature on November 19, 2025 and November 19, 2026.
Interest Rate Swap Agreements. In connection with entering into the Term Loans as discussed above, we entered into two receive variable/pay fixed interest rate swap agreements (“Interest Rate Swaps”) with maturities of November 19, 2025 and November 19, 2026, respectively, that will effectively lock-in the forecasted interest payments on the Term Loans’ borrowings over the four and five year terms of the loans. The Interest Rate Swaps are considered cash flow hedges and are recorded on our Consolidated Balance Sheets at fair value, with changes in the fair value of these instruments recognized in Accumulated other comprehensive income (loss) on our Consolidated Balance Sheets. During the three months ended March 31, 2022, we recorded a $4.9 million increase in fair value of Interest Rate Swaps.
As of March 31, 2022, the terms of our Interest Rate Swaps are as follows (dollar amounts in thousands):
43
The debt obligations by component as of March 31, 2022 are as follows (dollar amounts in thousands):
Our debt borrowings and repayments during the three months ended March 31, 2022 are as follows (in thousands):
At March 31, 2022, we had 39,460,029 shares of common stock outstanding, equity on our balance sheet totaled $742.6 million and our equity securities had a market value of $1.5 billion. During the three months ended March 31, 2022, we declared and paid $22.5 million of cash dividends.
Subsequent to March 31, 2022, we declared a monthly cash dividend of $0.19 per share on our common stock for the months of April, May and June 2022, payable on April 29, May 31, and June 30, 2022, respectively, to stockholders of record on April 21, May 23, and June 22, 2022, respectively.
At-The-Market Program. We have separate equity distribution agreements (collectively, “Equity Distribution Agreements”) to offer and sell, from time to time, up to $200.0 in aggregate offering price of shares of our common stock. As of March 31, 2022, no shares had been issued under the Equity Distribution Agreements. Accordingly, at March 31, 2022, we had $200.0 available under the Equity Distribution Agreements.
Available Shelf Registrations. We have an automatic shelf registration statement on file with the SEC and currently have the ability to file additional automatic shelf registration statements to provide us with capacity to publicly offer an indeterminate amount of common stock, preferred stock, warrants, debt, depositary shares, or units. We may from time to time raise capital under our automatic registration statement in amounts, at prices, and on terms to be announced when and if the securities are offered. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of the offering. Our shelf registration statement expires on February 17, 2025.
44
During the three months ended March 31, 2022, we granted restricted stock and performance-based stock units as follows:
Critical Accounting Policies
Our consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q are prepared in conformity with U.S. generally accepted accounting principles for interim financial information set forth in the Accounting Standards Codification as published by the Financial Accounting Standards Board, which require us to make estimates and assumptions regarding future events that affect the amounts reported in our financial statements and accompanying footnotes. We base these estimates on our experience and assumptions regarding future events we believe to be reasonable under the circumstances. Actual results could differ from those estimates and such differences may be material to the consolidated financial statements. We have described our most critical accounting policies in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our Annual Report on Form 10-K for the year ended December 31, 2021. There have been no material changes to our critical accounting policies or estimates since December 31, 2021.
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There were no material changes in our market risk during the three months ended March 31, 2022. For additional information, refer to Item 7A as presented in our Annual Report on Form 10-K for the year ended December 31, 2021.
Item 4. CONTROLS AND PROCEDURES
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended). As of the end of the period covered by this report based on such evaluation our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, our disclosure controls and procedures were effective.
There has been no change in our internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II
OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
We are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, which in our opinion are not singularly or in the aggregate anticipated to be material to our results of operations or financial condition. Claims and lawsuits may include matters involving general or professional liability asserted against the lessees or borrowers related to our properties, which we believe under applicable legal principles are not our responsibility as a non-possessory landlord or mortgage holder. We believe that these matters are the responsibility of our lessees and borrowers pursuant to general legal principles and pursuant to insurance and indemnification provisions in the applicable leases or mortgages. We intend to continue to vigorously defend such claims and lawsuits.
Item 1A. RISK FACTORS
There have been no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
During the three months ended March 31, 2022, we did not make any unregistered sales of equity securities.
During the three months ended March 31, 2022, we acquired shares of common stock held by employees who tendered owned shares to satisfy tax withholding obligations. The average prices paid per share for each month in the quarter ended March 31, 2022 are as follows:
Total Number
of Shares
Maximum
Purchased as
Part of
Shares that May
Publicly
Yet Be
Paid per
Announced
Purchased
Period
Plan
Under the Plan
January 1 - January 31, 2022
February 1 - February 29, 2022
36,880
34.04
March 1 - March 31, 2022
Item 6. EXHIBITS
3.1
LTC Properties, Inc. Articles of Restatement (incorporated by reference to Exhibit 3.1.2 to the registrant’s Current Report on Form 8-K filed June 6, 2016)
Bylaws of LTC Properties, Inc. (incorporated by reference to Exhibit 3.2.2 to the registrant’s Annual Report on Form 10-K filed February 18, 2021)
31.1
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definitions Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant
Dated: April 28, 2022
By:
/s/ Caroline Chikhale
Caroline Chikhale
Executive Vice President, Chief Accounting Officer and Treasurer
(Principal Accounting Officer)
49